Losartan Potassium Tablet, Film Coated
Product Images NDC 64380-933

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 64380-933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 01

Chemical structure of the active ingredient Losartan Potassium, showing its molecular framework including chlorine and potassium ions, as depicted in the image.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 02

A line graph comparing the percentage of patients with a primary endpoint over study months between Atenolol (dotted line) and Losartan Potassium (solid line). The x-axis represents study duration in months (0-66), and the y-axis shows percentage of patients (0-16%). The graph includes an adjusted risk reduction statistic of 13% with p=0.021 for Losartan Potassium.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 03

A line graph comparing the percentage of patients experiencing fatal or non-fatal stroke over a 66-month study period, for Atenolol (dotted line) and Losartan potassium (solid line). The graph shows Losartan potassium with a lower cumulative percentage than Atenolol, indicating an adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 04

A forest plot comparing event rates and hazard ratios between Losartan Potassium and Atenolol in various patient subgroups, including age, gender, race, ISH status, diabetes, and history of cardiovascular disease. The plot shows hazard ratios with 95% confidence intervals for both primary composite and stroke (fatal/non-fatal) outcomes, illustrating comparisons of favorability between the two drugs.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 05

A Kaplan-Meier curve chart showing the percentage of patients with event over months, comparing Losartan potassium (solid line) versus placebo (dotted line). The chart indicates a risk reduction of 16.1% with Losartan potassium, with a p-value of 0.022, over a period up to 48 months.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 06

LOSARTAN POTASSIUM 25 mg tablets, USP film-coated oral tablets in a 30-count package. The label shows the drug name, strength, dosage form, NDC 64380-933-04, Rx only status, and distributor information as Strides Pharma Inc., East Brunswick, NJ. Manufacturer is Strides Pharma Science Limited, India.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 07

Label for Losartan Potassium Tablets USP 25 mg, film-coated tablets in a bottle of 90 count, manufactured by Vivimed Life Sciences Private Limited and distributed by Strides Pharma Inc., East Brunswick, NJ. The label includes dosage instructions, storage conditions, and a barcode.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 08

LOSARTAN POTASSIUM 25 mg tablets, USP label from Strides Pharma Science Limited, showing 1000 film-coated tablets. The label includes storage instructions, manufacturer details (Vivimed Life Sciences Private Limited, India), distributor address in New Jersey, and a barcode with NDC 64380-933-08. It notes prescription-only status and pharmacist dispensing instructions.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 09

LOSARTAN POTASSIUM 50 mg film coated tablets packaging label for oral use. The label shows the drug name, strength, NDC 64380-934-04, and states it is prescription only. Manufactured and distributed by Strides Pharma Science Limited, with product storage and handling instructions included. The package contains 30 tablets.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 10

Label for Losartan Potassium 50 mg Tablets, USP, film-coated tablets by Strides Pharma Science Limited. The label shows the NDC number 64380-934-05, indicates prescription use only, and states the package contains 90 film-coated tablets. Storage instructions and manufacturer details in India are included, along with a barcode.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 11

Label for Losartan Potassium Tablets USP 50 mg film-coated tablets by Strides Pharma Science Limited. The label includes NDC 64380-934-08, manufacturer details, Pharmacy dispensing instructions, package contains 1000 tablets, and storage instructions. Distributed by Strides Pharma Inc., East Brunswick, NJ.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 12

Losartan Potassium Tablets, USP 100 mg film-coated tablets packaged by Strides Pharma Science Limited. The label includes directions to dispense with a patient information leaflet, storage instructions, and details of labeler location in East Brunswick, NJ. Package contains 30 film-coated tablets.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 13

Losartan Potassium Tablets USP 100 mg film-coated tablets label. The label indicates prescription use, packaging contains 90 tablets, and is manufactured by Vimmed Life Sciences Private Limited, distributed by Strides Pharma Science Limited. Storage and dispensing instructions are provided, along with a barcode and NDC 64380-935-05.*

FDA Label Image

03375ec9 0e3a 40c2 8c77 De5d9fd21876 14

Label for Losartan Potassium Tablets, USP 100 mg film coated tablets by Strides Pharma Inc. The label includes storage instructions, manufacturer and distributor information, NDC 64380-935-08, and a barcode. It states the medication is prescription only and advises dispensing with an attached patient information leaflet. The package contains 1000 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.